| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $72.8M | +227.5% | -34.2% |
| Cost of Revenue | $0 | — | -100.0% |
| R&D Expense | $32.7M | -19.8% | -19.3% |
| SG&A Expense | $9.9M | +6.5% | -29.8% |
| Operating Income | $18.6M | +150.7% | -65.6% |
| Interest Expense | $3.3M | +316.7% | — |
| Pre-tax Income | $16.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $80.1M | -38.7% | -55.4% |
| Accounts Receivable | $69.2M | +452.4% | +691.2% |
| Inventory | $8.8M | -5.7% | +169.7% |
| Current Assets | $232.1M | +13.2% | +4.5% |
| Total Assets | $270.8M | +10.3% | +2.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$124.1M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$48.1M | — | — |
| Financing Cash Flow | $69.5M | — | — |
| Free Cash Flow | -$125.7M | — | — |
| -70.1% |
| Income Tax | $0 | -100.0% | — |
| Net Income | $16.8M | +146.4% | -70.1% |
| EPS (Basic) | $0.27 | +147.4% | -70.0% |
| EPS (Diluted) | $0.27 | +147.4% | -70.0% |
| $44.5M |
| +14.0% |
| -25.0% |
| Total Liabilities | $203.8M | +2.5% | +41.1% |
| Stockholders' Equity | $67.0M | +43.7% | -44.2% |